Why the study?
Does decreased right ventricular systolic function predict short- and long-term mortality in patients admitted for heart failure?
Does decreased right ventricular systolic function predict short- and long-term mortality in patients admitted for heart failure?
Decreased right ventricular systolic function (measured by TAPSE) and co-existing COPD are independent predictors of mortality in patients hospitalized for heart failure.
TAPSE assessment may refine mortality risk stratification in HF admissions; leaves open whether RV-targeted interventions improve survival.
Decreased RV systolic function as estimated by TAPSE is associated with increased mortality in patients admitted for HF, and is independent of other risk factors in HF including left ventricular function. The co-existence of COPD is also associated with an adverse prognosis independent of the RV systolic function.
No takes yet. Share an insight, caveat, or question.
Kjærgaard et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: